• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在用Survanta(一种改良的牛肺表面活性剂)治疗的早产儿血清中未能检测到表面活性剂蛋白特异性抗体。

Failure to detect surfactant protein-specific antibodies in sera of premature infants treated with survanta, a modified bovine surfactant.

作者信息

Whitsett J A, Hull W M, Luse S

机构信息

Division of Pulmonary Biology, Children's Hospital Medical Center, Cinncinati, Ohio.

出版信息

Pediatrics. 1991 Apr;87(4):505-10.

PMID:2011428
Abstract

Serum from premature infants enrolled in either single-dose or multidose surfactant replacement studies with bovine lung-based exogenous surfactant (Survanta) were analyzed for antibodies reactive with mixtures of bovine surfactant proteins SP-B and SP-C. Sera from 404 premature infants enrolled in single-dose studies and 1024 premature infants enrolled in multidose studies were analyzed, representing a total of 987 samples and 2743 serum samples, respectively. The sera were obtained from treated and control infants at the time of treatment and 1 week, 4 weeks, and 6 months thereafter. Polyclonal antisera generated in rabbits against the small molecular weight proteins were uniformly reactive with the bovine surfactant test antigens; however, antibodies reacting with the surfactant proteins were never detected by immunoblot analysis with the infant sera. Antibodies against common human viral antigens were readily detected in infant serum samples. The horseradish-peroxidase conjugated second antibodies (antihuman immunoglobin G or antihuman immunoglobins A, G, and M) used in the studies were highly reactive with both immunoglobin G and immunoglobin M classes of human antibodies. Therefore there was failure to detect specific immunological responses to the bovine surfactant proteins present in Survanta after single or multiple doses of exogenous surfactant administered in the perinatal period.

摘要

对参与单剂量或多剂量表面活性剂替代研究的早产儿血清进行分析,这些研究使用的是基于牛肺的外源性表面活性剂(固尔苏),检测其中与牛表面活性剂蛋白SP-B和SP-C混合物发生反应的抗体。分析了参与单剂量研究的404名早产儿血清以及参与多剂量研究的1024名早产儿血清,分别代表总共987个样本和2743份血清样本。这些血清是在治疗时以及治疗后1周、4周和6个月从治疗组和对照组婴儿身上获取的。用针对小分子蛋白在兔体内产生的多克隆抗血清与牛表面活性剂测试抗原呈一致反应;然而,通过婴儿血清免疫印迹分析从未检测到与表面活性剂蛋白发生反应的抗体。在婴儿血清样本中很容易检测到针对常见人类病毒抗原的抗体。研究中使用的辣根过氧化物酶偶联二抗(抗人免疫球蛋白G或抗人免疫球蛋白A、G和M)与人类抗体的免疫球蛋白G和免疫球蛋白M类别都有高度反应。因此,在围产期给予单剂量或多剂量外源性表面活性剂后,未能检测到对固尔苏中存在的牛表面活性剂蛋白的特异性免疫反应。

相似文献

1
Failure to detect surfactant protein-specific antibodies in sera of premature infants treated with survanta, a modified bovine surfactant.在用Survanta(一种改良的牛肺表面活性剂)治疗的早产儿血清中未能检测到表面活性剂蛋白特异性抗体。
Pediatrics. 1991 Apr;87(4):505-10.
2
Surfactant proteins and anti-surfactant antibodies in sera from infants with respiratory distress syndrome with and without surfactant treatment.
Pediatrics. 1991 Jul;88(1):84-9.
3
Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group.单剂量改良牛肺表面活性物质提取物(固尔苏)预防呼吸窘迫综合征的多中心试验。罗斯协作表面活性物质预防研究组
Pediatrics. 1990 Jun;85(6):1092-102.
4
Repeat surfactant therapy for postsurfactant slump.针对表面活性剂治疗后肺顺应性下降进行重复表面活性剂治疗。
J Perinatol. 2006 Jul;26(7):414-22. doi: 10.1038/sj.jp.7211533. Epub 2006 May 18.
5
Surfactant replacement: immunological considerations.表面活性剂替代疗法:免疫学考量
Eur Respir J Suppl. 1989 Mar;3:91s-96s.
6
Improved neonatal survival following multiple doses of bovine surfactant in very premature neonates at risk for respiratory distress syndrome.多次剂量牛肺表面活性物质用于有呼吸窘迫综合征风险的极早产儿后新生儿存活率提高。
Pediatrics. 1991 Jul;88(1):10-8.
7
[Pulmonary surfactant and the immune system].[肺表面活性物质与免疫系统]
Monatsschr Kinderheilkd. 1992 Jan;140(1):57-61.
8
Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.在患有呼吸窘迫综合征的早产儿中,使用单剂量重组牛肺表面活性剂进行通气后表面活性剂替代疗法:一项多中心、双盲、随机试验的最终分析及与类似试验的比较。表面活性剂-TA研究组
Pediatrics. 1990 Nov;86(5):753-64.
9
Comparison of rSP-C surfactant with natural and synthetic surfactants after late treatment in a rat model of the acute respiratory distress syndrome.在急性呼吸窘迫综合征大鼠模型中晚期治疗后重组表面活性蛋白C(rSP-C)表面活性剂与天然及合成表面活性剂的比较。
Br J Pharmacol. 1998 Jul;124(6):1083-90. doi: 10.1038/sj.bjp.0701931.
10
Reduction of neonatal mortality after multiple doses of bovine surfactant in low birth weight neonates with respiratory distress syndrome.多剂量牛肺表面活性物质对低体重呼吸窘迫综合征新生儿死亡率的降低作用
Pediatrics. 1991 Jul;88(1):19-28.

引用本文的文献

1
A multicenter, randomized, double-blind trial of a new porcine surfactant in premature infants with respiratory distress syndrome.一项针对患有呼吸窘迫综合征的早产儿的新型猪肺表面活性物质的多中心、随机、双盲试验。
Einstein (Sao Paulo). 2014 Oct-Dec;12(4):397-404. doi: 10.1590/S1679-45082014AO3095.
2
Lung surfactants for neonatal respiratory distress syndrome: animal-derived or synthetic agents?用于新生儿呼吸窘迫综合征的肺表面活性剂:动物源制剂还是合成制剂?
Paediatr Drugs. 2002;4(8):485-92. doi: 10.2165/00128072-200204080-00001.
3
A risk-benefit assessment of natural and synthetic exogenous surfactants in the management of neonatal respiratory distress syndrome.
天然和合成外源性表面活性剂治疗新生儿呼吸窘迫综合征的风险效益评估
Drug Saf. 1998 May;18(5):321-37. doi: 10.2165/00002018-199818050-00002.
4
Surfactant replacement therapy.表面活性剂替代疗法。
Thorax. 1996 Nov;51(11):1137-54. doi: 10.1136/thx.51.11.1137.
5
Utilization of modified surfactant-associated protein B for delivery of DNA to airway cells in culture.利用修饰的表面活性物质相关蛋白B将DNA递送至培养的气道细胞。
Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2547-51. doi: 10.1073/pnas.91.7.2547.
6
Pulmonary surfactant therapy.肺表面活性物质疗法
West J Med. 1995 Jan;162(1):43-50.
7
A 2-year follow up of babies enrolled in a European multicentre trial of porcine surfactant replacement for severe neonatal respiratory distress syndrome. Collaborative European Multicentre Study Group.
Eur J Pediatr. 1992 May;151(5):372-6. doi: 10.1007/BF02113261.